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Adult skeletal muscle has the remarkable property of regenerating after
damage, owing to satellite cells and myogenic precursor cells becoming
committed to adult myogenesis to rebuild the muscle. This process is
accompanied by the continuing presence of macrophages, from the phago-
cytosis of damaged myofibres to the full re-formation of new myofibres. In
recent years, there has been huge progress in our understanding of the
roles of macrophages during skeletal muscle regeneration, notably concern-
ing their effects on myogenic precursor cells. Here, we review the most
recent knowledge acquired on monocyte entry into damaged muscle, the
various macrophage subpopulations, and their respective roles during the
sequential phases of muscle repair. We also discuss the role of macrophag-
es after exercise-induced muscle damage, notably in humans.
Introduction
Skeletal muscle, the most abundant tissue in humans,
constitutes a highly adaptable and malleable tissue,
responding to environmental and physiological
demands. The high adaptability of skeletal muscle
results from its well-known sensitivity to stimuli such as
contractile activity (endurance exercise, electrical stimu-
lation, and denervation), loading conditions (resistance
training and microgravity), substrate supply (nutritional
interventions), hormonal profile (thyroid hormone and
testosterone), and environmental factors (hypoxia).
Moreover, alteration of skeletal muscle plasticity is
involved in the pathophysiology of various diseases,
especially degenerative dystrophies [1]. Furthermore,
adult skeletal muscle possesses the remarkable capacity
to regenerate after injury, owing to the properties of a
pool of cells, the satellite cells [2], that are capable of
restoring muscle function throughout an individual’s
lifespan. Under steady-state conditions, muscle stem
cells (satellite cells) are quiescent, and located between
the plasma membrane and the basal lamina surrounding
the myofibre. After an injury, satellite cells are activated,
becoming myogenic precursor cells (MPCs), proliferate,
migrate towards each other, differentiate, and finally
fuse to form new myofibres. Inflammation is always
associated with the process of muscle regeneration,
although it is more or less pronounced, depending on
the extent and type of damage. The presence of inflam-
matory cells, especially macrophages, was described in
several experimental models more than 35 years ago.
From the late 2000s, new tools, including transgenic
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mouse strains and sorting of cell populations from the
muscle, allowed a deeper analysis of the phenotypes and
functions of immune cells during skeletal muscle repair,
and the demonstration of important roles of macro-
phages in this process.
Are there any resident macrophages
in normal adult steady-state muscle?
In normal adult skeletal muscle, macrophages are barely
detectable. They have been observed in the interstitial
space, and are more numerous in the perimysium (the
connective tissue that surrounds muscle fascicles) and
the epimysium (the connective tissue that surrounds the
whole muscle, also called the fascia), where they are
located near to the vessels and capillaries [3–5]. More
recent calculations in humans have shown that macro-
phages are rare in the parenchyma (approximately one
macrophage for five myofibres [6]). This was confirmed
in mouse skeletal muscle, where the main location for
resident macrophages is the epimysium [7]. Tangential
sectioning of the whole muscle allows the cell wealth of
this thin layer to be revealed. It is therefore possible to
observe and compare the respective concentrations of
resident macrophages in the epimysium and in the mus-
cle parenchyma (Fig. 1).
Macrophages are essential for skeletal
muscle regeneration
Macrophages are mainly derived from blood mono-
cytes that have crossed the vessel endothelial barrier to
reach the tissue. Macrophages have long been known
to be associated with skeletal muscle regeneration.
They appear in the damaged areas a few hours after
injury in various models, such as toxin injection (lido-
caine, barium chloride, notexin, and cardiotoxin)
[8–10], partial excision [11], and eccentric exercise
[12,13]. The first signal(s) causing the entry of mono-
cytes into the injured muscle is (are) still unknown.
Neutrophils are the first leukocytes to appear in the
damaged areas, within the very first hours after injury,
but only a few studies have explored their role. Sys-
temic injection of antibodies against granulocytes
impairs muscle regeneration and decreases the number
of both neutrophils and macrophages in the damaged
areas, although examination of leukocytes was not per-
formed with specific antibodies [14]. Similarly, block-
ing of CD11b binding leads to inhibition of leukocyte
entry a few hours after muscle injury [15]. Here, again,
the numbers of neutrophils and macrophages were not
assessed with specific antibodies, and the muscle tissue
was not further analysed. In contrast, in the b2-inte-
grin CD18-deficient mouse, it has been shown that the
recruitment of neutrophils (which express Ly6G) into
the damaged muscle, but not that of macrophages
(which express F4/80), is reduced, suggesting that neu-
trophils and macrophages are independently recruited
into the injured muscle [16]. In this experiment, the
number of injured myofibres was reduced in CD18-
deficient mice as compared with wild-type (WT) mice
at early time points after injury, and muscle regenera-
tion parameters (kinetics of regenerating myofibres,
cross-sectional area of the new fibres, and expression
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Fig. 1. Macrophage location in normal skeletal muscle. Tangential sections of normal adult muscle allow observation of the surrounding
connective tissue of the muscle, the epimysium or fascia. In (A), haematoxylin and eosin staining shows the high cellularity of the fascia,
surrounding the muscle parenchyma itself. (B) [same muscle as in (A)], (C) and (D) show examples of F4/80 immunostaining (red), which is
specific for murine macrophages. Many cells residing in the epimysium are macrophages, whereas only scarce positive cells are observed
between the myofibres. Blue, Hoechst. Bar: 50 lm.
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of embryonic myosin heavy chain by regenerating
myofibres) were improved [16], suggesting a protective
effect of neutrophil depletion. Similarly, inhibition of
monocyte/macrophage recruitment into the muscle
(e.g. in CCR2-deficient or MCP-1-deficient mice [17–
19], or in the presence of blocking antibodies against
macrophage colony-stimulating factor receptor [20];
see below) does not alter neutrophil entry into muscle.
The impairment of muscle regeneration in these condi-
tions suggests that neutrophils play a marginal role in
skeletal muscle repair. Resident cells may also partici-
pate in the recruitment of circulating monocytes into
the damaged muscle. A recent study of the role of
mast cells, which are immune sentinels in the tissues,
has shown that the stimulation and inhibition of mast
cell degranulation stimulate and block neutrophil entry
into the muscle, respectively [21]. Unfortunately, the
effect on monocytes/macrophages was not assessed in
this work. Resident macrophages located in the fascia
also participate in the recruitment of monocytes after
muscle injury. In CD11b-diphtheria toxin (DT) recep-
tor (DTR) mice, the human receptor for DT is
expressed under the control of the CD11b promoter,
making these cells sensitive to DT. In chimeric mice
obtained after WT bone marrow transplantation into
CD11b-DTR recipients, intravenous injection of DT
induces ablation of resident fascia macrophages. In
these conditions, recruitment of circulating monocytes
into injured muscle is dramatically reduced [7]. MPCs
have been also shown to attract monocytes in vitro
through the secretion of a series of effectors [uroki-
nase-type plasminogen activator, CX3CR1, CCL2,
CCL22, and vascular endothelial growth factor
(VEGF)] [22]. The study of the respective roles of mast
cells, neutrophils and resident muscle cells in the
recruitment of circulating monocytes requires further
investigation to establish the kinetics of immune cell
entry during the very first steps of the inflammatory
response after muscle injury.
Neutrophils rapidly disappear from the regenerating
muscle. In most of the regeneration models, the neu-
trophil number peaks at 24 h after injury, and then
quickly drops; neutrophils are no longer detectable
after 36–48 h. By contrast, the number of macrophag-
es continuously increases during this period of time.
Indeed, the macrophage number increases by eight-
fold and 19-fold, respectively, at day 1 and day 3 after
crush injury [5], and by 30–50-fold and 150–200-fold,
respectively, at day 1 and days 3–4 following cardio-
toxin injury, which is a more inflammatory model
[18,23]. The macrophage number also increases by
30% 3 days after eccentric exercise in humans [6]. An
intriguing observation is the persistence of macrophages
during the whole process of skeletal muscle regenera-
tion. Soon after injury, macrophages are first associated
with the necrotic myofibres, where they phagocytose
damaged myofibres and muscle debris. Once phagocyto-
sis has ended, macrophages are still present in the
regenerating areas, in even higher numbers, and are
tightly associated with MPCs and young, regenerating
myofibres. When differentiation and fusion are
completed, the number of macrophages drops to a very
low level [10,23]. Several studies have attempted to
analyse the role of macrophages during skeletal muscle
regeneration. To this end, several strategies were devel-
oped to block the entry of monocytes into the injured
muscle.
Injection of antibodies against macrophage colony-
stimulating factor receptor, which is expressed by circu-
lating monocytes, impairs muscle regeneration while
dramatically decreasing the number of macrophages
present in the damaged areas [20]. Intravenous injec-
tion of clodronate-containing liposomes into WT mice,
or of DT into CD11b-DTR mice, leads to a drastic
decrease in the number of monocytes in the circulation
(~ 90% of monocyte depletion is reached within 12 h,
and it stays maximal for another 12 h, before the num-
ber returns to the normal value). Notably, although
granulocytes, especially neutrophils, express CD11b,
they are not targeted by DT in the CD11b-DTR model
[24,25], providing a specific tool with which to study
monocytes/macrophages. Partial monocyte depletion
during the first 24 h after injury induces delay and
impairment of skeletal muscle regeneration, character-
ized by the persistence of some necrotic myofibres and
of inflammatory cells 9 days after injury, and the
appearance of interstitial fat 14 days after injury
[23,26]. Moreover, when the recruitment of circulating
monocytes is totally prevented in the first 24 h after
injury, muscle regeneration is totally inhibited, with the
persistence of necrotic fibres until 7 days after injury
[23]. By contrast, depletion of circulating monocytes
from 2 days after injury does not alter muscle regenera-
tion, showing that monocytes are recruited at once, at
the time of injury [23]. Several studies have used vari-
ous mouse strains and bone marrow transplantation
experiments to demonstrate the requirement for macro-
phages for efficient muscle regeneration. Mice deficient
in either the chemokine receptor CCR2 or its main
ligand CCL2/MCP1 show impaired muscle regenera-
tion, characterized by a decrease in the diameter of the
new myofibres, a reduced number of capillaries, and
fat accumulation. This is always associated with a
dramatic decrease in macrophage infiltration into the
muscle [17,18,27,28]. This effect is reversed by WT
bone marrow transplantation into deficient recipients
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[18,19,29,30], and CCR2/ bone marrow transplanta-
tion into WT recipients phenocopies the total CCR2/
phenotype [30]. These studies have shown that mono-
cyte entry into the injured muscle mainly occurs through
the CCR2–CCL2 axis. CXCL16, another chemokine,
has also been shown to regulate monocyte/macrophage
entry into the injured muscle [29]. Similarly, other
molecular systems involved in cell migration, such as
urokinase-type plasminogen activator [31–33] and
b3-integrin [34], are required for proper regeneration, as
they regulate monocyte/macrophage entry into the dam-
aged muscle. Altogether, these studies demonstrate that
macrophages are indispensable for postinjury skeletal
muscle regeneration.
Phenotypes of macrophages during
skeletal muscle regeneration
From the very first analyses of inflammatory cells dur-
ing skeletal muscle regeneration, various types of mac-
rophage have been described. Pioneering work on rats
has shown that macrophages expressing ED2+ (the
scavenger receptor CD163) are resident macrophages,
and that they are not associated with phagocytosis of
necrotic myofibres [3]. Soon after injury, ED1+
(CD68) macrophages, which are not observed in nor-
mal muscle, infiltrate the damaged areas and become
associated with phagocytosis of muscle debris. In con-
trast, ED2+ macrophages are not found in these
necrotic areas, but have been subsequently observed in
regenerating areas, once phagocytosis has ended [10].
The heterogeneity of monocyte and macrophage pop-
ulations has been investigated extensively. Jung et al.
[35] described the CX3CR1GFP/GFP knock-in mouse, in
which green fluorescent protein (GFP)+ cells are mostly
monocytes and their tissue descendants. Mouse mono-
cytes comprise at least two phenotypically distinct sub-
sets [36]. The main subset of Ly6Cpos(Gr1pos)
CX3CR1loCCR2hiCD62Lpos cells produces high levels
of tumor necrosis factor-a (TNF-a), interleukin (IL)-1,
and nitric oxide. These cells have a short half-life during
tissue damage, and migrates to inflamed tissues. The
Ly6Cneg(Gr1neg)CX3CR1hiCCR2lo/negCD62Lneg subset
is smaller in size, and is found in inflamed and resting
tissues [36]; on the basis of their high secretion of
VEGF, Ly6Cneg monocytes are considered to be proan-
giogenic [37]. Both populations can infiltrate damaged
tissues [38–40], where they differentiate into macrophag-
es or dendritic cells and have different functions.
In the tissues, macrophages can adopt different phe-
notypes according to their environment [41,42], and
they may switch from one phenotype to another,
exhibiting high plasticity [43]. Several macrophage
polarization profiles have been described, mainly from
in vitro studies, each profile expressing a specific panel
of markers, including cytokines, chemokines, growth
factors, and cell surface antigens [44]. The existence of
these phenotypes in vivo has been poorly assessed, and
it is likely that macrophages exhibit a variety of phe-
notypes ranging between the four main activation
states that have been described in vitro [42,44]. Two
polarization states were first described, mirroring
Th1–Th2 polarization. The classically activated (M1)
macrophages, induced by bacterial moieties such as
lipopolysaccharide or interferon-c, secrete Th1 chemo-
kines (CXCL9 and CXCL10) and proinflammatory
cytokines (IL-1, TNF-a, IL-6, etc.). An alternatively
activated (M2) macrophage phenotype was originally
discovered as a response to the Th2 cytokine IL-4. M2
macrophages show high-level expression of scavenging
mannose and galactose receptors, a phenotype of low
IL-12/high IL-10 expression, and expression of the
CCL17, CCL22 and CCL24 chemokines. These cells
participate in polarized Th2 responses, help with para-
site clearance, dampen inflammation, promote tissue
remodelling and tumour progression, and have immu-
noregulatory functions. In an attempt to distinguish
between various M2 macrophages found in either
chronic inflammation or tissue repair, the M2 popula-
tion has been subdivided into: M2a (after exposure to
IL-4 or IL-13), associated with fibrogenesis and angio-
genesis; M2b (triggered by immune complexes in com-
bination with IL-1b or lipopolysaccharide); and M2c
or anti-inflammatory/deactivated macrophages (trig-
gered by IL-10 or glucocorticoids), associated with the
resolution of inflammation and tissue repair [41]. The
heterogeneity and plasticity of macrophage functional
states indicate that typical M1 and M2 phenotypes are
extremes of a spectrum encompassing a plethora of
functional states [44]. Indeed, in in vivo pathophysio-
logical conditions – which are characterized by a
diversity and temporal evolution of activating signals
– macrophages with intermediate or overlapping phe-
notypes have been observed.
The use of the CX3CR1GFP/+ mouse helped in anal-
ysis of the recruitment of monocytes in regenerating
skeletal muscle [23]. Normal muscle contains only
CX3CR1hiLy6Cneg macrophages. Soon after toxic
injury, only CX3CR1loLy6Cpos (or F4/80posLy6Cpos)
monocytes infiltrate the injured muscle. This monocyte
subset expresses CCR2 and, accordingly, it is dramati-
cally reduced in CCR2-deficient mice, leading to
defects in muscle regeneration [45]. One day after
injury, this population declines, whereas the number of
CX3CR1hi/Ly6Cneg (or F4/80posLy6Cneg) monocytes/
macrophages greatly increases, partly because of the
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capacity of this cell subset to proliferate. RT-PCR
analyses showed that the first subset (CX3CR1lo
Ly6Cpos) to invade regenerating muscle expresses
higher levels of TNF-a and IL-1b, whereas the
CX3CR1hiLy6Cneg subset expresses high levels of
IL-10 and transforming growth factor-b [23,46]. The
sequential presence of an F4/80posLy6Cpos proinflamma-
tory macrophage population and then of an F4/
80posLy6Cneg anti-inflammatory macrophage population
is later followed by the appearance of population of mac-
rophages – probably coming from F4/80posLy6Cneg
– in which both proinflammatory and anti-inflammatory
markers are dampened at the very end of muscle
repair [46].
This sequential presence of proinflammatory and
then anti-inflammatory macrophages has been
recently confirmed during muscle regeneration in
humans. Injury was achieved by a series of volun-
tary eccentric contractions plus electrostimulation at
the time of maximum contraction. This leads to a
sequence of myofibre necrosis/regeneration through-
out the muscle. Regenerating areas are well charac-
terized by both CD56 labelling (which labels satellite
cells, MPCs, and young, newly forming, myofibres in
humans) and embryonic myosin heavy chain label-
ling (which characterizes young regenerating myofi-
bres). Seven days after injury, macrophages
expressing M1 markers [inducible NO synthase and
cyclooxygenase (COX)-2] and M2 markers (argi-
nase 1, CD206, and CD163) were observed in 80%
of the regenerating areas, indicating that different
subsets of macrophages are present at the same time
in the same place within these regenerative areas.
However, M1 and M2 macrophage markers were
found to be differentially associated with regenerat-
ing areas containing or not containing myogenic cells
positive for myogenin, a transcription factor associ-
ated with terminal myogenic differentiation. Interest-
ingly, macrophages expressing M1 markers are
preferentially associated with regenerative areas con-
taining only proliferating MPCs, whereas macrophag-
es expressing M2 markers are mainly associated with
regenerative areas containing differentiating myogenic
cells expressing myogenin [47].
Altogether, these findings show that injured skeletal
muscle recruits CCR2posLyC6pos monocytes. The first
steps of muscle regeneration, including phagocytosis
of necrotic debris and expansion of myogenic cells,
are associated with proinflammatory macrophages.
Then, the late steps of regeneration, at the time of
myogenic cell differentiation and myofibre formation,
are associated with anti-inflammatory macrophages
(Fig. 2). The sequential presence of macrophage sub-
populations suggests different and sequential roles of
macrophages in the myogenic process during muscle
regeneration.
Trophic effects of macrophages on
MPCs
As macrophages are present throughout the entire
regeneration process, several studies have explored
their role beyond phagocytosis, and particularly their
effects on MPCs, which are the progeny of activated
satellite cells. During muscle regeneration, MPCs pro-
liferate and migrate, finally undergoing terminal myo-
genic differentiation, and fuse to form myotubes and
new myofibres. A small subset of MPCs does not dif-
ferentiate but returns to an undifferentiated state to
replenish the satellite cell pool (self-renewal). In vitro,
murine or human MPCs follow the same kinetics, with
an expansion phase before migration and terminal dif-
ferentiation and fusion into myotubes (or self-
renewal).
The first in vitro analyses showed that macrophages
and macrophage-conditioned medium stimulate MPC
growth [22,48]. Macrophages are more efficient when
they are in contact with MPCs [22]. It was further
shown that these contacts mediate antiapoptotic sig-
nals [involving VCAM-1(CD106)/VLA-4(CD49d),
ICAM-1(CD54)/LFA-1(CD11a), CX3CL1/CX3CR1,
and PECAM-1(CD31)/PECAM-1(CD31)] on myo-
blasts, and even more so on myotubes [49]. Macro-
phages secrete mitogenic factors for MPCs, as they
stimulate MPC proliferation [22,50,51]. Their effects
on cell fusion have been debated since they were
reported to either stimulate [48,52] or inhibit/delay [51]
myogenic differentiation. Apart from the culture con-
ditions, which may induce huge differences in the
experimental outcomes, more recent studies have
established that macrophages exert different activities
on MPCs, depending on their inflammatory state. Pro-
inflammatory M1 macrophages stimulate MPC prolif-
eration and inhibit their fusion [23,47]. Conversely,
M2 macrophages (both M2a and M2c) stimulate myo-
genesis by promoting MPC commitment into terminal
differentiation and the formation of large myotubes
[47]. Accordingly, in vivo depletion of intramuscular
macrophages 5–6 days after injury leads to a decrease
in the size of the newly formed myofibres [23],
confirming the role of M2 macrophages in the late
steps of myogenesis and regeneration. We also
observed that M1 macrophages migrate more effi-
ciently towards MPCs, confirming earlier studies show-
ing that macrophages migrate towards muscle crush
extract [53]. Conversely, in in vitro assays, MPCs
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migrate towards other MPCs (in order to fuse) or
towards M2 macrophages, but much less towards M1
macrophages [47], indicating privileged interactions
between macrophages and MPCs.
Macrophages are well known to secrete a variety of
molecules, cytokines, and growth factors. Some of
them have been identified as having effects on MPC
proliferation, such as IL-6 [50,54] or TNF-a [55,56].
Accordingly, we have shown that M1 macrophages
prevent myogenesis through the secretion of high levels
of TNF-a, IL-6, and IL-1b, whereas M2 macrophages
secrete low levels of TNF-a and transforming growth
factor-b, which stimulate the formation of myotubes
[47]. VEGF has been shown to stimulate MPC growth
[47,57] and to promote engraftment of transplanted
MPCs into skeletal muscle [58]. Granulocyte colony-
stimulating factor, which is mainly secreted by M1
macrophages [59], stimulates MPC proliferation, and
is essential for the muscle regeneration process [60].
MPCs express a wide range of chemokine receptors
[61], whereas activated macrophages have been shown
to secrete specific panels of chemokines and attractants
[41,42]. It is likely that reciprocal attraction between
macrophages and MPCs involves chemokines. For
instance, macrophages express CXCL12 in vivo [62],
whereas MPCs express its receptor, CXCR4.
Accordingly, CXCL12 increases MPC migration, and
silencing of CXCR4 in MPCs prevents their fusion
[61]. An important regulator of muscle mass and
recovery is insulin-like growth factor (IGF)-1 [63]. A
Fig. 2. Macrophages during the time course of skeletal muscle regeneration. Skeletal muscle was injured with cardiotoxin. Muscle was
analysed on day 1, day 2, day 4 and day 8 after injury. The left panel shows haematoxylin and eosin (HE) staining; the middle panel shows
F4/80 immunostaining (red). The right panel shows immunolabelling for laminin (green), a component of the basal lamina surrounding each
myofibre, and CD206 (red), a marker of M2 macrophages (see text). On day 1, immune cells can be seen (black arrows), among which
macrophages (white arrows) invade the damaged muscle. Few cells express CD206, and they are located under the basal lamina, indicative
of phagocytosis of necrotic myofibres. On day 2, more macrophages are present. They are associated with necrotic myofibre phagocytosis
(arrows), and are also present in the interstitium (arrowheads). CD206-expressing cells are mainly outside the basal lamina (excluding the
possibility that they are myogenic cells, which have been shown to express CD206 in vitro). On day 4, a huge number of macrophages and
CD206pos cells are observed. They are associated with new, growing, regenerating myofibres. On day 8 after injury, the muscle has almost
completed the regeneration, and is composed of new, regenerated myofibres characterized by the central location of their nuclei. Only a
few macrophages and CD206pos cells remain in the tissue. *Necrotic myofibres, which are sometimes nonspecifically immunostained. Blue,
Hoechst. Bar: 50 lm.
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recent study performed in CCR2-deficient mice showed
that macrophages are likely to be the main source of
IGF-1 in the regenerating muscle [45]. In particular,
the intramuscular Ly6Cneg macrophage subset, which
presents an anti-inflammatory profile, expresses high
levels of IGF-1, which promotes muscle regeneration
[45] and dampens the inflammation [64]. Similarly,
blocking macrophage-derived IGF-1 reduces their abil-
ity to protect muscle cells from atrophy [65]. These
recent studies provide an initial list of molecular effec-
tors secreted in a timely way by macrophages that are
essential in the regulation of the sequential steps of
myogenesis during muscle regeneration, including
expansion of MPCs, migration, differentiation, and
fusion into new, multinucleated structures.
Transition from proinflammatory to
anti-inflammatory macrophages
during skeletal muscle regeneration
It was shown by several groups that injured skeletal
muscle recruits Ly6Cpos monocytes, whereas there is
no evidence for the recruitment of Ly6Cneg monocytes
at the time of injury or later. In a previous study, we
analysed monocyte subset recruitment into injured
muscle [23]. Circulating Ly6Cpos or Ly6Cneg monocyte
subsets were specifically labelled in the circulation
with fluorescent latex beads according to [66], as no
genetic lineage tracing tool to follow monocyte/
macrophage subsets is available. The appearance of
fluorescent bead-containing macrophages in the mus-
cle was then analysed 2–3 days after injury. Ly6Cneg
monocytes were never found to be recruited into the
injured muscle, whereas Ly6Cpos monocytes were
recruited into the muscle and were found to be con-
verted into Ly6Cneg cells in the tissue [23]. One can-
not exclude the possibility that the phagocytosis of
latex beads may alter the behaviour of the cells,
although several controls have been performed
[66,67]. However, the kinetics were analysed over very
short periods of time (2–3 days). In addition, mono-
cyte depletion from 2 days after injury does not alter
skeletal muscle regeneration, indicating that no more
monocytes are recruited from the blood to the injured
muscle after day 2. Furthermore, in mouse deficient
for cbl-b, a ubiquitin ligase involved in macrophage
maturation, skeletal muscle regeneration is impaired,
owing to increased expression of RANTES, despite
an unchanged number of macrophages [68]. This also
argues for a single wave of monocytes being recruited
at the time of injury, followed by intratissue matura-
tion of macrophages. Accordingly, macrophage size
and F4/80 expression increase with time [23]. These
results show that injured muscle recruits only Ly6Cpos
monocytes, which are converted into Ly6Cneg mono-
cytes within the muscle tissue during regeneration.
The cellular and molecular mechanisms responsible
for the transition from proinflammatory to anti-
inflammatory macrophages are poorly known. This
transition must be precisely regulated. For instance,
increasing M1 signalling leads to defects in muscle
regeneration, as shown in mice defective for the CREB
–Cebpb axis [69]. Several studies have shown that
interference with the sequence of macrophage polariza-
tion states leads to a defect in muscle regeneration. In
particular, it appears to be essential for the proinflam-
matory phase to occur before the switch towards the
anti-inflammatory phase. Inhibiting interferon-c alters
macrophage function and impairs muscle regeneration
[70]. Intramuscular injection of IL-10 at early time
points after injury also impairs muscle regeneration,
probably by preventing MPC proliferation [46]. Injec-
tion of antibody against IL-10 at late time points after
injury alters muscle regeneration [46], a result con-
firmed in IL-10-deficient mice [71]. The macrophage
phenotypic transition, which is crucial for proper mus-
cle regeneration, is partly controlled by mitogen-acti-
vated protein kinase phosphatase-1. By restricting p38
mitogen-activated protein kinase activation (which
leads to Akt activation), mitogen-activated protein
kinase phosphatase-1 allows timely macrophage skew-
ing, thereby permitting resolution of inflammation as
tissue fully recovers [46].
Do macrophages participate in muscle
regeneration occurring after exercise?
Most of the models of muscle regeneration involve
rodents and use aggressive techniques. Injection of
venom toxin is particularly useful, because it triggers a
very reproducible time course of regenerative events.
Moreover, this model is highly inflammatory, allowing
for the investigation of immune cells. However, it is
not physiologically relevant. The question remains of
whether macrophages are involved in a physiological
context, e.g. after exercise-induced muscle damage
(EIMD). Most of the studies published so far have
been performed in humans, and they usually rely on
eccentric exercises, performed in one or two bouts.
According to the topic of this review, we focus here
only on studies describing inflammation at the cellular
level. In almost all protocols, an increase in circulating
leukocytes is observed, particularly an increase in neu-
trophil number and then in monocyte number, notably
in the hours that follow the exercise, the monocyte
number remaining high for 3–4 days [72–77]. Whereas
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they are almost absent from normal untrained muscle,
macrophages have constantly been detected in the
muscle biopsies from 24 h after the exercise, their
number reaching a plateau in 3–4 days [78–81].
Recently, an interesting investigation into the polymor-
phism of CCR2 and CCL2 has revealed the associa-
tion of some single-nucleotide polymorphism with
EIMD (blood levels of creatine kinase, which is a mar-
ker of muscle damage, soreness, and strength recovery)
and strength gain, confirming the tight relationship
between macrophages and muscle remodelling after
exercise [82,83]. Finally, circulating leukocytes show
similar transcriptomic signatures before and immedi-
ately at the end of a 30-min exercise, whereas their sig-
nature is completely changed 2 h later, when the
inflammatory response starts to take place [84]. These
studies indicate that macrophages participate in muscle
recovery after damaging exercise.
These indications and evidence obtained from experi-
mental data showing that macrophages are necessary
for a good muscle regeneration question the use of
inhibitors of inflammation to help muscle regeneration/
recovery. EIMD includes delayed-onset muscle sore-
ness, which is often treated with nonsteroidal anti-
inflammatory drugs (NSAIDs). These are inhibitors of
the activity of COX, some of them being specific for the
COX2 member of the COX family. COX2 is important
in macrophage functions. It participates both in the
immune response, through the production of prosta-
glandin E2, and in the resolution of inflammation.
Indeed, PGE2 at high concentrations feeds back to inhi-
bit COX2 and 5-lipoxygenase (production of proinflam-
matory leukotrienes), while inducing 15-lipoxygenase
(production of anti-inflammatory lipoxins), thus exhib-
iting anti-inflammatory effects [85–87]. Many studies
have examined the effects of NSAIDs after EIMD.
However, compilation of the data is extremely difficult,
because of the extreme variation in the exercise model
(time, intensity and duration, arm or leg, one or two
bouts, etc.), the subjects (trained or not), the drug itself
(there are a variety of NSAIDs, with different actions
and side effects), the dose of the drug, the time point(s)
at which the drug is administered, and, finally, the
parameters that are evaluated (reviewed in [88,89]). An
attempt to summarize the data follows. Three main
types of NSAID effect on muscle are observed after
exercise: (a) in both humans and rats, positive effects of
NSAIDs on muscle force recovery and/or delayed-onset
muscle soreness are reported – a lower extent of muscle
damage is also observed, particularly when NSAIDs
are given before the exercise [90–96]; (b) also, in various
species (human, rabbit, and mouse), no effect of
NSAIDs is observed, except for a decrease in soreness
in human studies [97–101]; and (c) some studies, all per-
formed in rodents, have shown a negative effect of
NSAIDs and/or the inhibition of COX2 activity (by a
specific inhibitor in COX2-deficient mice) during mus-
cle regeneration. This is associated with a decrease in
the number of immune cells, especially macrophages,
leading to a decrease in the diameter of the new myofi-
bres and to the establishment of fibrosis [102–105]. One
study in humans reported better recovery a few days
after exercise under NSAID treatment, although a defi-
cit in the force of the treated patients was reported
1 month later, suggesting a negative effect in the long
term despite a short-term benefit [106]. In the same
way, a study analysed the effects of icing the muscle just
after injury in rodents (a practice used in some sports),
and showed a detrimental effect of icing on regenera-
tion, with smaller fibres and more collagen deposition,
associated with a delay in ED1+ macrophage infiltra-
tion within the muscle [107].
NSAIDs have pleiotropic roles. They alter muscle
protein synthesis, which is, of course, important for
muscle recovery [89] and they also act on connective
tissue cells [88]. Moreover, they have a detrimental
effect on satellite cells themselves, as they inhibit satel-
lite cell/MPC proliferation, as shown in human studies
[108,109]. However, the animal data described above
suggest that the inhibition of macrophage functions
after injury is not beneficial for muscle regeneration.
Further analyses, notably in humans, where injury
models are less aggressive than in animals, and thus
induce less damage, are required to assess the specific
role of macrophages in EIMD. Moreover, knowledge
on the timing of their involvement during the course
of muscle regeneration will be of interest to enable effi-
cient manipulation of the inflammatory compartment
for the benefit of skeletal muscle recovery and homeo-
stasis.
Conclusion
Our current knowledge on inflammation during postin-
jury skeletal muscle regeneration allows us to envisage
inflammation as a beneficial – and not a detrimental
– event. It also sheds new light on how the environ-
ment contributes to the regulation of myogenic cell
fate/behaviour. Further studies are required to pre-
cisely identify the molecular mode of action of macro-
phages, particularly at the late stages of muscle
regeneration, on myogenic cells, and also on fibrogenic
and endothelial cells. Indeed, macrophages stimulate
angiogenesis in various contexts [110], and they partici-
pate in fibrogenesis, although the respective properties
of M1 and M2 macrophages in this process remain to
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be established [111]. It is of particular importance to
understand how macrophages are beneficial during
muscle regeneration and how they are detrimental for
the muscle tissue in degenerative myopathies character-
ized by chronic inflammation.
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